Which has the lower trailing P/E, DXCM or MDLN?

DXCM has the lower trailing P/E: DXCM trades at 29.46 and MDLN at 32.33. P/E is one valuation measure and does not by itself establish which business is cheaper.

Is DXCM or MDLN more profitable?

DXCM runs the higher net margin — DXCM at 20.12% versus MDLN at 3.31%.

DexCom, Inc. (DXCM) vs Medline Inc. (MDLN)

A side-by-side comparison of DexCom, Inc. and Medline Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of July 31, 2026. Differences are shown without an overall score or investment verdict.

DXCM

DexCom, Inc.

$32.20B

$83.45HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

MDLN

Medline Inc.

$33.22B

$39.28HealthcareDelayed quote: Jul 31, 2026, 4:00 PM EDT

Total return — DXCM vs MDLN

growth of $100 · dividends reinvested · last 1y

DXCM +12.3%MDLN -4.6%DXCM compounded faster

DXCM MDLN

DXCM vs MDLN: by the numbers

•MDLN is the larger company ($33.22B vs $32.20B market cap).
•DXCM trades at the lower trailing earnings multiple (29.46 vs 32.33 P/E), one valuation lens rather than an overall verdict.
•DXCM converts more revenue to profit (20.12% vs 3.31% net margin).

Metrics side by side

Valuation

Metric	DXCM	MDLN
P/E ratio	29.46	32.33
Forward P/E	28.75	25.83
P/S ratio	5.88	1.11
P/B ratio	11.14	2.86
PEG ratio	0.67	N/A
EV / EBITDA	23.22	14.31
FCF yield	4.81%	4.73%

Profitability

Metric	DXCM	MDLN
Gross margin	62.79%	24.04%
Operating margin	22.92%	7.04%
Net margin	20.12%	3.31%
ROE	38.14%	8.55%
ROIC	16.61%	5.69%

Growth (annualized)

Metric	DXCM	MDLN
Revenue CAGR (5Y)	18.03%	N/A
EPS CAGR (5Y)	10.31%	N/A
FCF CAGR (5Y)	69.49%	N/A
Total return CAGR (5Y)	-10.37%	N/A

Frequently asked

Which has the lower trailing P/E, DXCM or MDLN?: DXCM has the lower trailing P/E: DXCM trades at 29.46 and MDLN at 32.33. P/E is one valuation measure and does not by itself establish which business is cheaper.
Is DXCM or MDLN more profitable?: DXCM runs the higher net margin — DXCM at 20.12% versus MDLN at 3.31%.

Go deeper

Full DXCM analysis Full MDLN analysis Interactive comparison tool

Dig into the metrics

DexCom P/E ratio Medline P/E ratio DexCom dividend yield Medline dividend yield DexCom ROE Medline ROE DexCom operating margin Medline operating margin DexCom revenue growth Medline revenue growth DexCom free cash flow Medline free cash flow

DexCom & Medline appear in these rankings

Fastest Revenue Growth Stocks Highest ROE Stocks Highest FCF Yield Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified July 31, 2026.